Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Kane Biotech
About
Kane Biotech is a biotechnology company that engages in the research and development of products to prevent and disperse biofilms.
- 1 - 10
Details
- Last Funding Type
- Pre-seed
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2001
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Kane Biotech Inc., a biotechnology company, engages in the research and development of products to prevent and disperse biofilms in medical and industrial applications. Its products include ALEDEX, an antimicrobial/antibiofilm composition comprising protamine sulfate and chlorhexidine, with applications in anti-infective medical device coatings, animal care and dairy, and food processing industries; DispersinB, an antibiofilm enzyme that inhibits, as well as disperses microbial biofilms, with applications in wound care, medical devices, oral care, and animal healthcare; and a toothpaste and mouthwash additive based on competence stimulating peptide technology for preventing and dispersing dental plaque biofilms. The company was founded in 2001 and is headquartered in Winnipeg, Canada.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 5, 2020 | Post-IPO Debt | $1.48M | 1 | — | — | Detail |
| Jan 1, 2003 | Pre-seed | — | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Pivot Financial Inc
|
— | Post-IPO Debt |
Genesys Venture
|
— | Pre-seed |
